The Family Heart Foundation, the leading research, education and advocacy organization focused on genetic dyslipidemias, has launched the Lp(a) AW(a)RE(TM) initiative to engage key U.S. healthcare ...

PCSK9 inhibition may be a suitable alternative for statin-intolerant patients, and recent data demonstrated its efficacy as ...

A new three-pronged blood test can highlight people with a nearly tripled risk for heart attack, Wake Forest University ...

Lp(a)] has emerged as a major, genetically determined risk factor in atherosclerotic cardiovascular disease (ASCVD) and ...

A combined analysis of blood tests to measure three biomarkers linked to higher risk of cardiovascular disease—lipoprotein a ...

A panel discussion titled “Elevated Lipoprotein(a): Raise Your Game and Lower Your (Risk) Score?” presented at the American Heart Association (AHA) Scientific Sessions 2023, which convened in ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The Skeptical ...

When considering the risk factors for heart disease, some conditions may come readily to mind: obesity, unhealthy diet, and high cholesterol. People who have a parent or close relative with heart ...

An international team led by a University of Pittsburgh School of Medicine scientist has created a first-of-its-kind resource ...

Not all cholesterol is bad! High-density lipoprotein (HDL), or “good cholesterol,” acts like the cleanup crew, sweeping away ...